albunorm 20%
- Name:
albunorm 20%
- Company:
Octapharma Ltd
- Active Ingredients:
- Legal Category:
Product subject to medical prescription which may not be renewed (A)
Patient Information Leaflet Patient Information Leaflet last updated on medicines.ie: 07/12/20
(Click to Download)Click on this link to Download PDF directly
Octapharma Ltd
Company Products
| Medicine Name | Active Ingredients |
|---|---|
| Medicine Name albunorm 20% | Active Ingredients Human Albumin |
| Medicine Name Fibryga, 1 g, powder and solvent for solution for injection/infusion | Active Ingredients Human Fibrinogen |
| Medicine Name gammanorm | Active Ingredients Human Normal Immunoglobulin |
| Medicine Name LG-octaplas solution for infusion | Active Ingredients Human Plasma Proteins |
| Medicine Name Nuwiq powder and solvent for solution for injection | Active Ingredients simoctocog alfa |
| Medicine Name Octaplex 1000 IU coagulation factor IX per vial, powder and solvent for solution for infusion | Active Ingredients Human Prothrombin Complex |
| Medicine Name Octaplex 500 IU coagulation factor IX per vial, powder and solvent for solution for infusion | Active Ingredients Human Prothrombin Complex |
| Medicine Name Panzyga 100 mg/ml solution for infusion | Active Ingredients Human Normal Immunoglobulin |
| Medicine Name Wilate powder and solvent for solution for injection | Active Ingredients Factor VIII, von Willebrand factor |
When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.
Updated on 7 December 2020 PIL
Reasons for updating
- Change to section 6 - date of revision
Updated on 9 April 2020 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 9 April 2020 PIL
Reasons for updating
- Change to section 2 - excipient warnings
Updated on 9 April 2020 PIL
Reasons for updating
- Change to section 2 - excipient warnings
Updated on 9 April 2020 PIL
Reasons for updating
- Change to section 2 - excipient warnings
Updated on 9 April 2020 PIL
Reasons for updating
- Change to section 2 - excipient warnings
Updated on 9 April 2020 SPC
Reasons for updating
- Change to section 4.4 - Special warnings and precautions for use
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 18 June 2019 SPC
Reasons for updating
- File format updated to PDF
Legal category: Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
Updated file format
Updated on 15 August 2018 SPC
Reasons for updating
- File format updated to PDF
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 15 August 2018 SPC
Reasons for updating
- File format updated to PDF
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 29 May 2018 SPC
Reasons for updating
- Change to section 7 - Marketing authorisation holder
- Change to section 8 - Marketing authorisation number(s)
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 21 May 2018 PIL
Reasons for updating
- Change to section 6 - marketing authorisation holder
- Change to section 6 - marketing authorisation number
Updated on 15 November 2016 PIL
Reasons for updating
- New PIL for new product
Updated on 15 November 2016 PIL
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 8 March 2016 PIL
Reasons for updating
- Change of manufacturer
- Change to date of revision
Updated on 12 February 2015 SPC
Reasons for updating
- New SPC for new product
Legal category: Product subject to medical prescription which may not be renewed (A)
Updated on 12 February 2015 PIL
Reasons for updating
- New PIL for medicines.ie